|
|
||||||||
Cutting Edge |
Department of Laboratory Medicine and Pathology, Center for Immunology, Cancer Center, University of Minnesota Medical School, Minneapolis, MN 55455
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
/pre-B cell-stimulating factor). | Materials and Methods |
|---|
|
|
|---|
The Jurkat E6-1 cell line was obtained from the American Type Culture Collection (ATCC, Manassas, VA). The ZAP-70-deficient Jurkat mutant P116 was obtained from Drs. R. Abraham and B. Irvin (Mayo Clinic, Rochester, MN) (14). The SLP-76-deficient mutant J14 and Src homology 2 domain-containing leukocyte protein of 76 kDa (SLP-76)-reconstituted J14-76-11 were provided by Dr. A. Weiss (University of California, San Francisco, CA) (15). Jurkat, P116, and J14 were maintained in RPMI 1640 supplemented with 10% FCS (Atlanta Biologicals, Norcross, GA), L-glutamine, and penicillin/streptomycin (complete medium). P116 cells expressing ZAP-70 constructs and J14-76-11 cells were maintained in complete medium containing 2 mg/ml G418 (Mediatech-Cellgro, Herndon, VA).
Abs and other reagents
The SLP-76-specific Ab was provided by Dr. G. A. Koretzky
(University of Pennsylvania, Philadelphia, PA). The
1 integrin-specific mAb TS2/16 was obtained
from ATCC. Human CXCL12 (SDF-1
/PBSF) was purchased from PeproTech
(Rocky Hill, NJ) or R&D Systems (Minneapolis, MN). The CXCR4-specific
mAb was purchased from R&D Systems. The phosphotyrosine-specific mAb
4G10 was purchased from Upstate Biotechnology (Lake Placid, NY). The
FLAG-specific mAb M2 was obtained from Sigma (St. Louis, MO).
The anti-hemagglutinin (anti-HA) mAb 16B12 was purchased from
Covance (Richmond, CA). Human fibronectin was purchased from
Invitrogen/Life Technologies (Carlsbad, CA).
DNA constructs
The pIRES-EGFP-HA-ZAP-70 and pIRES-EGFP-HA-ZAP-70(K369R) bicistronic plasmid expression constructs encoding for HA-tagged forms of human ZAP-70 have been previously described (16). The pIRES-EGFP-HA-ZAP-70(Y292F) mutant construct was created by site-directed mutagenesis using the QuickChange Site Directed Mutagenesis kit (Stratagene, La Jolla, CA). Mutations were confirmed by sequencing at the University of Minnesota Microchemical Facility (Minneapolis, MN). The pEF-FLAG-SLP-76 construct was provided by Dr. G. A. Koretzky (17).
Transfections
P116 cells (10 x 106 cells) were transfected by electroporation as previously described (16) using a BTX (San Diego, CA) Square Wave electroporator with 25 µg each of the SLP-76 and ZAP-70 constructs. After electroporation, cells were incubated in complete medium for 1620 h at 37°C. The generation of stable P116 transfectants expressing ZAP-70 constructs was performed as previously described (18). Screening for transfectants was performed 2024 days following the electroporation by flow cytometry. Bulk populations of transfectants expressing HA-tagged ZAP-70 constructs were collected and analyzed in migration assays (as described below).
Migration assays
Transfected Jurkat cells were serum-starved in migration medium
(RPMI 1640 containing 1% BSA, 10 mM HEPES buffer, pH 6.9) for
4 h. Migration assays were performed in transwell chambers with
5-µm polycarbonate membrane (catalog no. 3421; Costar, Cambridge, MA)
precoated with 20 µg/ml fibronectin or BSA on both sides of the
filter as previously described (19). Human CXCL12 was
diluted to appropriate concentrations in migration medium and added to
the lower chamber of the transwells. Medium alone was added to wells
left unstimulated. The membranes were placed on top, and 5 x
105 serum-starved cells were loaded into the
upper chamber in migration medium. The cells were allowed to migrate
for 2.5 h at 37°C in 5% CO2, and migrated
cells were collected, pelleted, and resuspended in 200 µl of ice-cold
FACS buffer (HBSS supplemented with 10% bovine calf serum and 0.2%
sodium azide). A fixed number of 9-µm latex reference beads
(Interfacial Dynamic, Portland, OR) and 25 µl of propidium iodide
(Sigma) were added to each tube, and samples were analyzed by flow
cytometry (19). An aliquot of each cell population was
also analyzed by flow cytometry using standard procedures to assess the
expression of CXCR4,
4,
5, and
1 integrin.
The percentage of migration of cells expressing comparable levels of
HA-ZAP-70, as assessed by enhanced green fluorescent protein (eGFP)
expression (16), was calculated as previously described
(19).
Preparation of cell lysates
Cell lysates were prepared as previously described (20). Briefly, cells were serum starved for 4 h, washed in OPTI-MEM (Invitrogen) and incubated in OPTI-MEM with CXCL12 at the indicated concentrations at 37°C for the indicated amount of time. The cells were then lysed by adding an equivalent volume of 2x lysis buffer (2% Nonidet P-40, 0.5% sodium deoxycholate, 300 mM NaCl, 100 mM Tris-HCl, 2 mM sodium vanadate, 20 µg/ml leupeptin, 20 µg/ml aprotinin, and 2 mM PMSF). Cell lysates were clarified by centrifugation (13,000 x g, 4°C for 30 min). Unstimulated cells were incubated for 0 min with CXCL12 and immediately lysed as described above.
Immunoprecipitation and Western blotting
Immunoprecipitations from cell lysates (10 x 106 cells) were performed as previously described (20) with 5 µl anti-SLP-76 Ab or 4 µg anti-FLAG M2 mAb. Immunoprecipitates were separated by SDS-PAGE, and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA) for analysis by Western blotting.
Western blotting was performed as previously described (20). Blots were incubated with primary Ab (1/1000 dilution of anti-SLP-76, 0.5 µg/ml anti-phosphotyrosine mAb 4G10, or 0.5 µg/ml anti-FLAG M2 mAb in PBS containing 5% milk) for 2 h at room temperature, washed, and then incubated with HRP-conjugated goat anti-mouse IgG (Caltag Laboratories, Burlingame, CA) for 1 h at room temperature. The membranes were washed and developed using ECL (Pierce, Rockford, IL). For repeated immunoblotting, membranes were stripped as previously described (20) and reprobed using the procedure described above.
| Results and Discussion |
|---|
|
|
|---|
1 integrin expression, as flow cytometric
analysis demonstrated comparable levels of expression of CXCR4,
4
1, and
5
1 integrins on P116
T cells and wild-type Jurkat T cells (Ref. 16 and data not
shown).
|
4
1 integrin, or
5
1 integrin (data not
shown).
|
Activation of ZAP-70 during TCR stimulation leads to the tyrosine
phosphorylation of the adapter protein SLP-76, which
plays a critical role in T cell activation and development
(23). We analyzed the ability of CXCL12 stimulation to
regulate tyrosine phosphorylation of SLP-76 in
wild-type and P116 Jurkat T cells. Treatment of wild-type Jurkat T
cells with CXCL12 resulted in a 3- to 4-fold increase in tyrosine
phosphorylation of SLP-76 that was detectable within 2
min of CXCL12 stimulation (Fig. 3
A). In contrast, treatment of
ZAP-70-deficient P116 T cells with CXCL12 did not result in any
detectable tyrosine phosphorylation of SLP-76 at any of
the time points tested (Fig. 3
A), even though comparable
amounts of SLP-76 were immunoprecipitated from wild-type Jurkat T cells
and P116 T cells. Doses of CXCL12 ranging from 3 ng/ml to 1 µg/ml
also did not result in tyrosine phosphorylation of
SLP-76 in P116 T cells (data not shown). CXCL12-mediated tyrosine
phosphorylation of SLP-76 was dependent on the kinase
activity of ZAP-70, because expression of wild-type ZAP-70, but not
kinase-inactive ZAP-70, in P116 T cells restored CXCL12-mediated
tyrosine phosphorylation of SLP-76 (Fig. 3
B). Furthermore, expression of the Y292F ZAP-70 mutant in
P116 T cells resulted in enhanced CXCL12-mediated tyrosine
phosphorylation of SLP-76 when compared with P116 T
cells expressing wild-type ZAP-70. These results suggest that CXCR4
receptor stimulation activates ZAP-70 tyrosine kinase activity.
|
4
1 integrin,
and
5
1 integrin (data
not shown).
|
1 integrins expressed on Jurkat T cells (data
not shown). Furthermore, the ability of ZAP-70 to enhance the migration
of P116 T cells was also observed when using BSA-coated filters,
although the overall level of migration in response to CXCL12 was
dramatically reduced when compared with migration through
fibronectin-coated filters (Fig. 2
1 integrin signaling to ZAP-70 does not play a
major role in the effects of ZAP-70 on T cell migration in this
system. These results demonstrate a novel function for ZAP-70 in regulating T lymphocyte migration in response to the CXCR4 chemokine receptor ligand CXCL12. Although CXCR4 signaling resulted in ZAP-70-dependent tyrosine phosphorylation of SLP-76, we did not observe any effect of SLP-76 expression on the low level of migration of SLP-76-deficient Jurkat T cells. Thus, our results suggest that ZAP-70-dependent regulation of T cell migration in response to CXCL12 does not involve ZAP-70-dependent tyrosine phosphorylation of SLP-76. This was somewhat surprising, given reports that SLP-76 may be involved in TCR-mediated modulation of the actin cytoskeleton (25). Previous studies have suggested a role for PI 3-K, the GTPase cdc42, and NO in regulating CXCR4-mediated cell migration (6, 8, 12, 26, 27). The relationship between ZAP-70 and these other signaling proteins in coordinating the biochemical events required for T cell migration remains unclear. However, it is interesting to note that B cell receptor-mediated activation of PI 3-K requires Syk tyrosine kinase activity (28) and that PI 3-K has been implicated in the regulation of various GTPases (29). Thus, ZAP-70 might mediate CXCR4 signaling to PI 3-K and other downstream effectors. Although CXCR4 ligation also activates the mitogen-activated protein kinase pathway (6), mitogen-activated protein/extracellular signal-related kinase kinase inhibitors do not block CXCL12-dependent migration (8, 26).
Although it is currently unclear whether other chemokine receptors might also regulate lymphocyte migration via ZAP-70, several aspects of CXCR4 chemokine receptor signaling suggest the possibility of unique components to biochemical signaling initiated by CXCR4. First, in contrast to other chemokine receptors, CXCR4 is capable of initiating prolonged activation of protein kinase B and extracellular signal-related kinase 2 (10). Second, costimulatory effects of CXCL12 on T cell activation have been noted (30). Thus, ZAP-70 may represent an important point of convergence between chemokine receptors and the TCR that may possibly be involved in mediating the costimulatory effects of CXCL12 on T cell activation (30). It will be important in future studies to determine the role of ZAP-70 in regulating these other responses of T cells to CXCR4 stimulation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Yoji Shimizu, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, MMC 334/312 Church Street SE, Minneapolis, MN 55455. E-mail address: shimi002{at}umn.edu ![]()
3 Abbreviations used in this paper: PI 3-K, phosphatidylinositol 3-kinase; CXCR, CXC chemokine receptor; HA, hemagglutinin; SLP-76, Src homology 2 domain-containing leukocyte protein of 76 kDa; eGFP, enhanced green fluorescent protein. ![]()
Received for publication May 14, 2001. Accepted for publication June 13, 2001.
| References |
|---|
|
|
|---|
2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759.[Medline]
1 and
2 integrins on T lymphocytes. Immunity 4:179.[Medline]
-chemokine, stromal cell-derived factor-1
, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 273:23169.
stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 95:2505.
-chemokine receptor CXCR4-mediated signaling pathways. Blood 97:608.
triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13:1699.
-induced lymphocyte polarization and chemotaxis. J. Immunol. 163:4001.
1 in an SLP-76-deficient T cell. Science 281:413.
1 integrin-mediated adhesion by T cell receptor signaling involves ZAP-70 but differs from signaling events that regulate transcriptional activity. J. Immunol. 165:4941.
1 integrin function by epidermal growth factor and heregulin-
has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Mol. Biol. Cell 10:2861.
1 integrin signaling and T lymphocyte migration. J. Immunol. 164:1143.
-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J. Immunol. 166:3067.This article has been cited by other articles:
![]() |
N. A. Shahabi, K. McAllen, and B. M. Sharp Stromal cell-derived factor 1-{alpha} (SDF)-induced human T cell chemotaxis becomes phosphoinositide 3-kinase (PI3K)-independent: role of PKC-{theta} J. Leukoc. Biol., March 1, 2008; 83(3): 663 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, S. Aydin, L. Bergui, G. D'Arena, L. Bonello, P. Omede, M. Scatolini, O. Jaksic, G. Chiorino, et al. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential Blood, December 1, 2007; 110(12): 4012 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Patrussi, C. Ulivieri, O. M. Lucherini, S. R. Paccani, A. Gamberucci, L. Lanfrancone, P. G. Pelicci, and C. T. Baldari p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells Blood, September 15, 2007; 110(6): 1730 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Park, I. Park, D. Lee, Y. B. Choi, H. Lee, and Y. Yun The adaptor protein Lad associates with the G protein {beta} subunit and mediates chemokine-dependent T-cell migration Blood, June 15, 2007; 109(12): 5122 - 5128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. DeFord-Watts, J. A. Young, L. A. Pitcher, and N. S. C. van Oers The Membrane-proximal Portion of CD3 {epsilon} Associates with the Serine/Threonine Kinase GRK2 J. Biol. Chem., June 1, 2007; 282(22): 16126 - 16134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deaglio, T. Vaisitti, S. Aydin, E. Ferrero, and F. Malavasi In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia Blood, August 15, 2006; 108(4): 1135 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Gevrey, B. M. Isaac, and D. Cox Syk Is Required for Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine) J. Immunol., September 15, 2005; 175(6): 3737 - 3745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vicente-Manzanares, A. Cruz-Adalia, N. B. Martin-Cofreces, J. R. Cabrero, M. Dosil, B. Alvarado-Sanchez, X. R. Bustelo, and F. Sanchez-Madrid Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav Blood, April 15, 2005; 105(8): 3026 - 3034. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Lee, T.-H. Lee, R. Zagozdzon, S. Avraham, A. Usheva, and H. K. Avraham Carboxyl-Terminal Src Kinase Homologous Kinase Negatively Regulates the Chemokine Receptor CXCR4 through YY1 and Impairs CXCR4/CXCL12 (SDF-1{alpha})-Mediated Breast Cancer Cell Migration Cancer Res., April 1, 2005; 65(7): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Fischer, J. C. Mercer, A. Iyer, M. J. Ragin, and A. August Regulation of CXC Chemokine Receptor 4-mediated Migration by the Tec Family Tyrosine Kinase ITK J. Biol. Chem., July 9, 2004; 279(28): 29816 - 29820. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Han, K. H. Hong, J. Ko, K. S. Rhee, M. K. Hong, J. J. Kim, Y. H. Kim, and S. J. Park Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells J. Leukoc. Biol., July 1, 2004; 76(1): 195 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goda, A. C. Quale, M. L. Woods, A. Felthauser, and Y. Shimizu Control of TCR-Mediated Activation of {beta}1 Integrins by the ZAP-70 Tyrosine Kinase Interdomain B Region and the Linker for Activation of T Cells Adapter Protein J. Immunol., May 1, 2004; 172(9): 5379 - 5387. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Kremer, T. D. Humphreys, A. Kumar, N.-X. Qian, and K. E. Hedin Distinct Role of ZAP-70 and Src Homology 2 Domain-Containing Leukocyte Protein of 76 kDa in the Prolonged Activation of Extracellular Signal-Regulated Protein Kinase by the Stromal Cell-Derived Factor-1{alpha}/CXCL12 Chemokine J. Immunol., July 1, 2003; 171(1): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Z. Fernandis, R. P. Cherla, and R. K. Ganju Differential Regulation of CXCR4-mediated T-cell Chemotaxis and Mitogen-activated Protein Kinase Activation by the Membrane Tyrosine Phosphatase, CD45 J. Biol. Chem., March 7, 2003; 278(11): 9536 - 9543. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Choe, E. S. Schoenberger, J. E. Groopman, and I.-W. Park HIV Nef Inhibits T Cell Migration J. Biol. Chem., November 22, 2002; 277(48): 46079 - 46084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inngjerdingen, K. M. Torgersen, and A. A. Maghazachi Lck is required for stromal cell-derived factor 1alpha (CXCL12)-induced lymphoid cell chemotaxis Blood, May 29, 2002; 99(12): 4318 - 4325. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Liao, A.-K. Shirakawa, J. F. Foley, R. L. Rabin, and J. M. Farber Human B Cells Become Highly Responsive to Macrophage-Inflammatory Protein-3{alpha}/CC Chemokine Ligand-20 After Cellular Activation Without Changes in CCR6 Expression or Ligand Binding J. Immunol., May 15, 2002; 168(10): 4871 - 4880. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ticchioni, C. Charvet, N. Noraz, L. Lamy, M. Steinberg, A. Bernard, and M. Deckert Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration Blood, May 1, 2002; 99(9): 3111 - 3118. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |